The user, who had a heart attack 17 years ago, reflects on how stent technology has improved significantly since then, with modern stents being ultra-thin and highly sophisticated, and notes that GLP-1 drugs may reduce the need for stent procedures. The user, who has benefited from stent technology, is grateful for the innovators and tinkerers who are helping improve stents day by day, and ...